Afghanistan vs Iran: 10_Insured export credit exposures, short term
Afghanistan
50.00 million BU
in 2025
Iran
66.00 million BU
in 2025
Afghanistan rank
188th
Iran rank
185th
10_Insured export credit exposures, short term over time
- Afghanistan
- Iran
How they compare
Iran currently reports 66.00 million BU against 50.00 million BU in Afghanistan, a difference of 16.00 million BU.
That makes Iran's figure about 1.3 times Afghanistan's.
Across all 21 years both countries report, Iran has been ahead every year.
Afghanistan ranks 188th and Iran ranks 185th of 210 countries.
Iran has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Afghanistan | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.20 million BU | 3.00 billion BU | 3.00 billion BU | Iran |
| 2010s | 22.70 million BU | 1.82 billion BU | 1.80 billion BU | Iran |
| 2020s | 45.67 million BU | 119.33 million BU | 73.67 million BU | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher 10_insured export credit exposures, short term, Afghanistan or Iran?
- Iran, at 66.00 million BU against 50.00 million BU in Afghanistan as of 2025.
- What is the difference in 10_insured export credit exposures, short term between Afghanistan and Iran?
- 16.00 million BU, with Iran ahead.
- How many years of comparable data are there for Afghanistan and Iran?
- 21 years are reported by both, from 2005 to 2025.
- How do Afghanistan and Iran rank globally for 10_insured export credit exposures, short term?
- Afghanistan ranks 188th and Iran ranks 185th of 210 countries.
- Where does this data come from?
- BIS, published as 10_Insured export credit exposures, short term (BU). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
ST refers to insured export credits with credit terms up to and including 12 months, except for transactions involving an insured manufacturing (pre-credit) risk with a risk period of more than 12 months, which are classified as medium/long-term (MLT).